Shoaib TH, Ibraheem W, Abdelrahman M, Osman W, et al. Exploring the potential of approved drugs for triple-negative breast cancer treatment by targeting casein kinase 2: Insights from computational studies. PLoS One 2023;18:e0289887.
PMID: 37578958